Fentanyl is a synthetic opioid 50 times more potent than heroin and 100 times more potent than morphine. Fentanyl continues to drive overdose deaths in San Francisco and in cities across the nation.
In October 2022, The San Francisco Department of Public Health (SFDPH) and Mayor London Breed announced the start of the City’s Overdose Prevention Plan, to reduce overdose deaths and address racial disparities. One of the strategic areas laid out in the plan is to “strengthen community engagement and social support for people at high risk for overdose.”
As part of this strategy, SFDPH is expanding naloxone distribution and training. Naloxone (also known as Narcan) is a lifesaving medication that reverses the effects of an opioid overdose.
How Performance is Measured
This measure counts the number of naloxone doses distributed by the SFDPH funded Drug Overdose Prevention and Education (DOPE) and the DPH Behavioral Health Services Naloxone Clearinghouse to DPH providers and community-based partner programs during the reporting period. Data is provided by the Drug Overdose Prevention and Education (DOPE) project under the National Harm Reduction Coalition and the DPH Behavioral Health Services Naloxone Clearinghouse. DPH sets an achievable target each year based on annual trends and the goals laid out in the Overdose Prevention plan.
The number displayed on the Scorecard Page represents the number of doses distributed to providers and community partners in the most recent quarter.
Additional Information
View the Department of Public Health’s Overdose Prevention Plan
City Performance Scorecards
This page is part of the City Performance Scorecards.